Gjennombrudd i Bukspyttkjertelkreft og Reguleringer i Endring

Kilder

• STAT: STAT+: A breakthrough in pancreatic cancer has experts excited — and braced for what’s to come
• Raps: Recon: FDA denies Hengrui-Elevar liver cancer drug for the third time; GSK to pursue FDA nod for Jemperli for rectal cancer - RAPS
• STAT: STAT+: All eyes on data on Biogen’s tau therapy
• STAT: Dementia study replicates promising outcomes following risk-reduction strategies - STAT
• STAT: Tau in the spotlight at Alzheimer’s conference - STAT

Oppsummeringen og talen er laget med KI. Kildelenkene viser opphavet og er ikke en anbefaling av TellMe fra mediene.